Compare RXO & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXO | CNC |
|---|---|---|
| Founded | 2022 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 18.7B |
| IPO Year | N/A | 2001 |
| Metric | RXO | CNC |
|---|---|---|
| Price | $13.72 | $39.35 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 17 |
| Target Price | $16.25 | ★ $40.06 |
| AVG Volume (30 Days) | 2.0M | ★ 7.2M |
| Earning Date | 02-04-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,940,000,000.00 | ★ $167,680,000,000.00 |
| Revenue This Year | $27.93 | $32.54 |
| Revenue Next Year | $3.52 | $0.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 53.85 | 14.57 |
| 52 Week Low | $10.43 | $25.08 |
| 52 Week High | $26.92 | $66.81 |
| Indicator | RXO | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 45.50 | 54.92 |
| Support Level | $13.75 | $38.02 |
| Resistance Level | $16.00 | $39.91 |
| Average True Range (ATR) | 0.76 | 1.26 |
| MACD | 0.05 | -0.09 |
| Stochastic Oscillator | 18.86 | 42.32 |
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.